-+ 0.00%
-+ 0.00%
-+ 0.00%

OneMedNet signs deal to supply de-identified clinical data to AI drug developer

PUBT·08/31/2026 12:35:20
Listen to the news
OneMedNet signs deal to supply de-identified clinical data to AI drug developer
  • OneMedNet signed a new agreement to deliver de-identified, full-fidelity clinical real-world data to an AI-driven drug development company.
  • Cohort feasibility completed within minutes; data validation finished within a week; contract signed within three weeks of initial contact.
  • Data deliveries are underway to support development and validation of AI models for drug discovery and development.
  • Deal highlights demand for first-party clinical datasets sourced directly from providers across OneMedNet’s iRWD network.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608310835PRIMZONEFULLFEED9818449) on August 31, 2026, and is solely responsible for the information contained therein.